MDL | MFCD00004438 |
---|---|
Molecular Weight | 304.44 |
Molecular Formula | C18H33NaO2 |
SMILES | CCCCCCCC/C=C\CCCCCCCC(O[Na])=O |
Na + /K + ATPase [2]
Oleic acid is the most common monounsaturated fatty acids (FA) in human adipocytes and other tissues. Oleic acid prompts cell proliferation and migration in high metastatic cancer cells via enhancing β-oxidation mediated by AMPK activation. Oleic acid inhibits cancer cell growth and survival in low metastatic carcinoma cells, such as gastric carcinoma SGC7901 and breast carcinoma MCF-7 cell lines [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT01042340 | Karolinska University Hospital|Karolinska Institutet |
Nutritional Intervention
|
December 2005 | Not Applicable |
NCT03054779 | Penn State University|Canola Council of Canada|University of Manitoba|Laval University|Unity Health Toronto|St. Boniface Hospital |
Cardiovascular Disease|Metabolic Syndrome
|
September 2014 | Not Applicable |
NCT01661764 | Vanderbilt University|National Cancer Institute (NCI)|Vanderbilt University Medical Center |
Colorectal Adenomatous Polyps
|
February 4, 2013 | Phase 2 |
NCT01674946 | University Hospital, Basel, Switzerland |
Echolocation
|
September 2011 | Phase 1 |
NCT03739463 | Université de Sherbrooke|Laval University |
PPROM
|
December 3, 2018 | Not Applicable |
NCT00535886 | UCSF Benioff Children´s Hospital Oakland|National Cattlemen´s Beef Association |
Cardiovascular Disease|Diabetes|Dyslipidemia
|
November 2005 | Not Applicable |
NCT01066091 | Yves Boirie|Centre de Recherche en Nutrition Humaine d´Auvergne|ITERG|Institut National de la Recherche Agronomique |
Healthy|Obesity
|
March 2010 | Not Applicable |
NCT01233778 | Penn State University|University of Manitoba |
Cardiovascular Disease
|
October 2010 | Not Applicable |
NCT00059254 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|The University of Texas Medical Branch, Galveston |
Obesity|Diabetes|Hyperlipidemia
|
September 2000 | Not Applicable |
NCT02841618 | Ohio State University |
Healthy Adults
|
January 2016 | Not Applicable |
NCT04641494 | University of Chester |
Obesity|Lung Functions|Inflammation|Lipid Disorder
|
November 11, 2016 | Not Applicable |
NCT04997122 | Instituto de Ciencia y Tecnología de Alimentos y Nutrición |
Healthy|Hypercholesterolemia
|
April 2, 2018 | Not Applicable |
NCT01043445 | Glostrup University Hospital, Copenhagen|University of Copenhagen |
Type 2 Diabetes
|
September 2009 | Not Applicable |
NCT04531410 | Karolinska Institutet|European Society of Pediatric Gastroenterology, Hepatology and Nutrition |
Cystic Fibrosis
|
October 25, 2021 | Not Applicable |
NCT01351012 | University of Manitoba|University of Toronto|Penn State University|Laval University |
Metabolic Syndrome
|
September 2010 | Not Applicable |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
H 2 O : 25 mg/mL ( 82.12 mM ; Need ultrasonic)
DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble or slightly soluble)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.2847 mL | 16.4236 mL | 32.8472 mL |
5 mM | 0.6569 mL | 3.2847 mL | 6.5694 mL |
10 mM | 0.3285 mL | 1.6424 mL | 3.2847 mL |
Add each solvent one by one: PBS
Solubility: 9.09 mg/mL (29.86 mM); Clear solution; Need ultrasonic and warming and heat to 60°C